Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE for Pneumococcal immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE was used for Pneumococcal immunisation.

Most Reported Side Effects for PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE

Side Effect Reports % Deaths Hosp.
Asthma 176 37.1% 1 96
Dyspnoea 175 36.8% 1 94
Drug ineffective 152 32.0% 3 51
Chronic obstructive pulmonary disease 140 29.5% 1 62
Therapeutic product effect incomplete 128 27.0% 1 50
Loss of personal independence in daily activities 114 24.0% 0 42
Bronchopulmonary aspergillosis allergic 105 22.1% 1 35
Bronchiectasis 99 20.8% 1 96
Gastrooesophageal reflux disease 94 19.8% 1 89
Wheezing 88 18.5% 1 84
Obstructive airways disorder 87 18.3% 1 85
Pyrexia 80 16.8% 4 62
Multiple allergies 76 16.0% 0 0
Hypertension 72 15.2% 1 50
Transient ischaemic attack 66 13.9% 1 62

Other Indications for PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE

Immunisation (281) Prophylaxis (99) Product used for unknown indication (87) Antibiotic prophylaxis (6) Infection prophylaxis (6)

Other Drugs Used for Pneumococcal immunisation

PNEUMOCOCCAL VACCINE, POLYVALENT 23 (15) PNEUMOCOCCAL VACCINE POLYVALENT (9)

Related Pages

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE Full Profile All Pneumococcal immunisation Drugs PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE Demographics PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE Timeline